When a vial lands on the bench and the purchase file is closed, one number tends to do most of the talking: the purity percentage. It is compact, comparable and easy to quote in a procurement note. But it answers a narrower question than most people assume, and where a purchase has to stay clearly research-use-only, a second result has to travel beside it — the identity result.
Purity describes how much of the detected material sits in the main peak. Identity describes whether that peak is the compound named on the label at all. Record one without the other and the research record has a gap in it: the material is documented as homogeneous, but not documented as what it says it is.
What a Purity Percentage Says and What It Leaves Out
An HPLC purity figure is a relative measurement. It tells a researcher what proportion of the detected signal, under the conditions of that assay, is attributable to the principal peak. It is a statement about homogeneity — that the sample is overwhelmingly one thing rather than a mixture — and homogeneity is a genuinely useful property in an in-vitro workflow. What it is not is a statement of naming. A result of ≥99% is compatible with more than one identity, and on its own it says nothing about which compound produced the peak being measured.
That distinction matters more in a catalogue context than in a single bench experiment, because catalogue language tends to compress. Research Sciences publishes headline lines such as ≥99% Verified Purity and UK Research Materials Over 99.1% Purity, and the FAQs describe peptides as typically supplied at ≥99% purity, HPLC tested, with the exact figure stated on the CoA. Those are the shop’s published figures at the time of writing; they should be reconfirmed on the live site and, more importantly, read as a range rather than as a per-vial guarantee. The batch CoA is the document that speaks for the specific vial in front of you.
Purity also does not screen for everything a laboratory might reasonably want to know. The site describes a full-spectrum testing framework in which purity and identity sit alongside heavy-metals and endotoxin evaluation, and its educational posts discuss techniques such as ICP-MS and endotoxin testing. Those are separate questions with separate methods. A purity percentage, however impressive, is not a substitute for any of them, and it is certainly not a substitute for the identity result printed on the same certificate.
Why Identity Sits at the Centre of an RUO Purchase
Research-use-only status is a claim about purpose and about the supply chain that supports it. Research Sciences labels its materials For Research Use Only – Not for Human Consumption, describes that labelling as its stated position in line with MHRA guidance, and makes clear that products are not medicines, medical devices, injectables, treatments or food supplements under UK law. None of that framing survives contact with a poorly documented vial. If a laboratory cannot show what the material was, it cannot convincingly show what the material was for. Identity testing is what closes that loop: it is the difference between a record that says “a high-purity sample” and a record that says “this batch of this compound, verified, with a certificate that can be opened and read”.
For a materials manager, that difference is practical rather than philosophical. It is the evidence trail that sits behind the RUO statement, and it is what makes a purchase defensible when an internal reviewer, a supervisor or a collaborator asks a straightforward question about provenance. The shop states plainly that its materials are not for human or veterinary use, and the documentation is the mechanism by which that boundary stays visible from order to bench.
Labels, ITRs and the limits of packaging cues
The site’s own documentation practices show how the two results are meant to be used together. Vial labels carry a reference combining the SKU code and expiry date — BPC10-03/27 is the format given — and that reference links to the corresponding CoA. Researchers are asked to quote it when contacting the shop about documentation. Two caveats are worth repeating. First, vial cap colours and other packaging may vary, and cap colour is not an indicator of identity, analytical quality or manufacturing origin. Second, restocked products may carry the same Internal Test Reference as earlier stock; an ITR links to associated sample testing reports, but it does not confirm that separate deliveries come from the same production lot or have had separate independent testing. Identity plus purity, read from the batch certificate, is the pair that actually answers the question.
Reading the Certificate as a Pair, Not a Headline
In practice, the discipline is simple to describe and easy to skip. Open the CoA that accompanies the specific batch, then read the identity result and the purity result together, as a pair, before the vial goes anywhere near a protocol. Check that the compound name matches the label, that the reference matches, and that the storage and handling guidance sits in the purchase file alongside the certificate. On Research Sciences, the Uk peptides range is described as carrying a CoA for every product, with HPLC results covering purity and identity, within a testing framework that later added heavy-metals and endotoxin screening. The homepage also lists “CoAs Janoshik Analytical Reports”, which is best read as a pointer: open and check the certificate that accompanies the specific batch rather than treating the line as a substitute for it.
What to check before the vial reaches the bench
A short checklist keeps both results visible for the whole order cycle. Does the listing name the compound and format exactly as the label will? Is a batch CoA reachable at or before delivery? Does that certificate carry identity and purity together, traceable to the label reference? Are storage instructions stated — lyophilised material at −20°C or below, sealed with desiccant, protected from moisture, heat and light, with repeated freeze–thaw cycles avoided? For in-vitro reconstitution, has the diluent volume and target assay concentration been recorded in the laboratory notebook, with the free reconstitution calculator treated strictly as a research aid and not a dosing tool? And does the paperwork repeat, plainly, that the materials are not for human or veterinary use?
Two everyday scenarios show why the pair matters. A restock arrives and the cap colour differs from the previous delivery: the correct response is neither alarm nor assumption, but to check the label reference, open the CoA and confirm that identity and purity both read as expected, while remembering what a shared ITR does and does not confirm. Or a laboratory wants a combined experiment: the shop does not supply blended peptides and recommends buying individual compounds and combining them only within a controlled experimental design — which means two identities and two purities to document, not one convenient blended figure.
The purchase stays clearly RUO when the documentation stays complete. Purity tells the laboratory how homogeneous the material is; identity tells it what the material is. Kept side by side on the same certificate, anchored to the same label reference, they give an in-vitro workflow the one thing a headline percentage never can — a record that answers both questions at once, for the batch actually in hand.